Organ-specific effects of 1,2-dimethylhydrazine in hamster.
Uptake and metabolism of the carcinogen 1,2-dimethylhydrazine (DMH) were compared in isolated epithelial cells from the colon and the small intestine. A new method was developed to separate colonic epithelial cells into surface columnar cells and crypt cells without the use of any proteolytic enzymes. Colonic columnar cell-enriched fraction exhibited DMH metabolism two to three times higher than that of crypt cells. The carcinogen binding was much lower in the small intestine as compared to the colon. In the small intestine, the crypt cell-enriched fraction showed higher carcinogen binding as compared to villus cells. Pyrazole was found to inhibit DMH binding by isolated small intestinal and colonic epithelial cells. The extent of inhibition was maximum in cells showing the greatest ability to incorporate DMH.
D019813:1,2-Dimethylhydrazine; D000478:Alkylation; D000818:Animals; D001711:Biotransformation; D002273:Carcinogens / Q000378:metabolism*; D002478:Cells, Cultured; D003106:Colon / Q000378:metabolism; D006224:Cricetinae; D004127:Dimethylhydrazines / Q000378:metabolism*; D004848:Epithelium / Q000378:metabolism; D007421:Intestine, Small / Q000378:metabolism; D008297:Male; D008647:Mesocricetus; D008763:Methylhydrazines / Q000378:metabolism*; D009928:Organ Specificity; D011720:Pyrazoles / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism
D002273:Carcinogens; D004127:Dimethylhydrazines; D008763:Methylhydrazines; D011720:Pyrazoles; C031280:pyrazole; D019813:1,2-Dimethylhydrazine; D013936:Thymidine